Because the proto-oncogene HMGA2 may play a crucial role in the transition of CIN into cervical cancer, treatments targeting HMGA2 might be potential therapeutic strategies. This evidence concerns the gene HMGA2 and cervical squamous intraepithelial neoplasia.